About us – IMMUMEDIC LLC
Competence center for modern immunotherapy & integrative oncology
IMMUMEDIC Limited is a Europe-wide competence center for immunological therapy concepts, therapy support, and scientifically based patient education.
Our focus is on dendritic cell therapy, complementary immunotherapies, and innovative strategies in biological cancer medicine.
In collaboration with specialized laboratories, clinics, physicians, and international research institutes, we support patients in navigating the complex field of modern immunotherapies and making informed individual treatment decisions.
Our focus areas
-
Individual immunotherapy planning, e.g., dendritic cell therapy, T-cell activation, tumor-targeted immune strategies
-
Therapy support & aftercare counseling, structured, patient-centered, and internationally networked
-
Access to specialist centers and research partners across Europe and worldwide
-
Medical information & patient education about the opportunities, limitations, and scientific basis of modern immunotherapy
-
Participation in research and publications on the further development of immunological therapies
Vision & Values
We believe that modern cancer treatment must do more than destroy tumor tissue.
It must:
-
strengthen rather than weaken,
-
be precise rather than nonspecific,
-
and have a biologically integrated rather than isolated effect.
The focus is always on the immune system as the key to cancer medicine.
Our values:
-
Transparency & reliable information
-
Individualized medical concepts
-
Scientifically validated principles
-
International networking & innovative perspectives
Our commitment
IMMUMEDIC is actively working to strengthen the bridge between medical progress and individual patient access. This includes:
-
Specialist publications and medical knowledge transfer
-
Development of digital information formats for those affected
-
Establishment of international cooperation networks between physicians, laboratories, clinics, and researchers
Andreas Rach, founder and managing director of IMMUMEDIC Limited, has been working in the field of integrative oncology and immunological therapies for over 10 years.
His focus is on how the immune system can be specifically strengthened and made therapeutically useful—scientifically sound, patient-oriented, and internationally focused.
With his book project
“Dendritic Cell Therapy – Immunological Cancer Therapy of the Future,”
he is committed to providing understandable, reliable, and well-prepared patient education.
IMMUMEDIC thus stands for a modern, responsible, and innovative form of support for immunological cancer therapies.